The Collagen Alpha-2 Chain Gene  by Tolstoshev, Paul & Crystal, Ronald G.
0022-202X/82/7901-060s$02.00/0 
THE .JOURNAL OF INVESTIGATIVE DERMATOLOGY, 79:60s-648, 1982 
Copyright © 1982 by The Williams & Wilkins Co. 
Vol. 79, Supplement 1 
Printed in U.S.A. 
The Collagen Alpha-2 Chain Gene 
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A number of DNA sequences specific for collagen mes­
senger RNAs and genes have been isolated, cloned in 
bacterial plasmids or bacteriophage, and studied in de­
tail. Such sequences have been used to study regulatory 
mechanisms underlying the production of type I collagen 
in fibroblasts in culture, fibroblasts after viral transfor­
mation, and in tissues and organs during embryonic and 
fetal development. It is clear that a variety of mecha­
nisms, transcriptional, translational and post-transla­
tional, are used by cells to regulate collagen production. 
The study of isolated collagen gene fragments coding for 
the a2 collagen chain in sheep and chick have shown 
that these genes are very large, and are interrupted by 
as many as 50 intervening sequences. Additionally, the 
structure of the genes in the regions coding for the 
helical regions of the protein provides evidence that 
collagen genes may have arisen from the reduplication 
of a DNA segment containing a primordial collagen gene 
sequence. The availability of specific cloned collagen 
gene sequences will allow the precise chromosomal lo­
cation of the collagen genes as well as the number and 
the linkage relationships between these genes. In addi­
tion, genetic disorders of connective tissue where alter­
ations in collagen structure are implicated will now be 
amenable to analysis at the DNA level. 
The development over the last decade of recombinant DNA 
technology, has enabled eukaryotic genes and fragments of 
these genes to be isolated, purified and studied in detail. Here, 
we wish to review such studies of the gene for one of the chains 
of type I collagen, the a2 collagen gene. 
The collagens represent one of the major classes of protein of 
vertebrate connective tissue and play a critical role in the 
structure, function and development of a wide variety of tissues 
and organs. There exist at least 5 different collagen types, and 
these represent the products of at least 9 distinct genes. The 
most ubiquitous and abundant collagen type is type I, repre­
senting the major collagen of skin, bone, tendon and lung, as 
well as other tissues [1]. Additionally, type I collagen likely 
plays a central role in the connective tissue abnormalities 
associated with several acquired and heritable disorders [2]. 
To understand the factors involved in regulating normal type 
I collagen gene expression and to investigate the nature of the 
defects underlying the pathogenesis of acquired and heritable 
disorders, a knowledge of the structure of the genes encoding 
type I collagen is required. Molecular approaches utilizing 
recombinant DNA technology have allowed the isolation and 
characterization of parts of the type I collagen lX2 chain gene 
from 3 species, sheep [3,4], chick [5,7], and humanl• These 
studies have provided insights into the structure and evolution 
of this gene, as well as yielding information about a wide range 
of mechanisms involved in regulating the expression of the 
genes for type I collagen. 
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METHODOLOGIES 
A number of technologies of molecular biology have contri­
buted to the ability to isolate and characterize the collagen a2 
gene. Some of the more important of these are as follows. 
1. Preparation of DNA Copies of Eukaryotic Messenger 
DNA 
The use of a viral enzyme, reverse transcroptase (RNA de­
pendent DNA polymerase) has enabled the copying of the 
nucleotide sequence of an mRNA molecule into a DNA com­
plement. This is generally achieved by using the 3' poly A 
segment found in most eukaryotic mRNAs as a template for an 
oligo dT primer on which the synthesis of the complementary 
strand is initiated. Such cDNA copies have now been prepared 
to a wide variety of mRNAs, including those for type I collagen 
mRNAs from several species [3,5-13]. Since such cDNAs con­
sist of a nucleotide sequence complementary to that of the 
template mRNA, they can be utilized as probes that, together 
with the techniques of molecular hybridization, permit the 
quantitation of the mRNA sequence in total RNA from any cell 
or tissue. 
A cDNA molecule can be converted enzymically from single­
stranded to double-stranded form, using either reverse tran­
scriptase or DNA polymerase. This is a prerequisite for inser­
tion of cDNA into a suitable vector, normally a bacterial 
plasmid. This plasmid can then be used to transform bacterial 
cells to generate cDNA clones of a particular mRNA sequence 
(see below). 
2. Restriction Endonucleases 
Restriction endonucleases are a class of nucleases which cut 
nucleic acids at sequence specific sites. These enzymes, pro­
duced by a wide variety of bacteria, recognize short sequences, 
and often leave self-complementary cohesive termini on DNA 
molecules by specific cleavage at staggered sites. Recombinant 
DNA molecules may be formed by joining 2 unrelated pieces of 
DNA terminated by the same restriction site. Over 100 of such 
restriction enzymes, each with their own specificity, are now 
known [14]. The ability of these enzymes to precisely cleave 
DNA has enabled the characterization, propagation and ampli­
fication in plasmids, bacteriophage and animal viruses of many 
DNA molecules. 
3. Vectors for Propagation of Foreign DNA 
60s 
Two major kinds of vectors are commonly used in recombi­
nant DNA research. The first are bacterial plasmids, which are 
covalently closed circular DNA molecules that have the ability 
to transform and replicate autonomously within bacterial cells. 
A number of such plasmids occur naturally and often carry 
genes conferring resistance to a particular antibiotic. Other 
plasmids have been constructed from parts of natural plasmids; 
among these is the commonly used E. coli plasmid, pBR322 
[15]. This plasmid carries the genes for resistance to the anti­
biotics ampicillin and tetracycline. Foreign pieces of DNA can 
be inserted into this plasmid, usually in such a way as to 
inactivate one of the antibiotic resistance genes. The recombi­
nant plasmids are then used to transform E. coli cells, and 
transformants carrying the recombinant plasmids are identified 
by their resistance to one, but not both, of the antibiotics 
carried by the parental pBR322. 
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Generally plasmids can be used to clone only relatively short 
pieces of DNA (up to 10 kilobases in length) and hence are 
most commonly used to clone double-stranded complementary 
DNA molecules and to subclone small parts of longer cloned 
DNAs isolated using bacteriophage vectors. A detailed discus­
sion of cDNA cloning techniques has recently been published 
[16]. 
The second major class of vectors are bacteriophage vectors, 
most of which are derivatives of the phage A. Such phage 
vectors contain a central restriction fragment of DNA which is 
not essential to the replication of the phage. The central piece 
of DNA can be excised and replaced by a piece of foreign DNA 
10-20 kilobases in size. DNA can be packaged into phage 
particles in vitro [17], the recombinant phage grown in a 
suitable E. coli host, and large amounts of the phage DNA 
prepared. A series of such bacteriophage vectors have been 
constructed [18,19] and are commonly used to construct DNA 
libraries [17,20] where the DNA from an organism is cleaved to 
a size of 15-20 kb and is then ligated between the two ends of 
the bacteriophage vector. The recombinant DNA molecules are 
then packaged in uitro to form infectious phage particles and 
are amplified by infecting and growing in an appropriate E. coli 
host. Usually consisting of 0.5 to 1 X 106 different recombinant 
phage, containing fragments of DNA, such libraries represent 
the entire genome of an organism. These phages can be stored 
indefinitely and aliquots used to screen for any gene sequence 
for which a suitable probe is available. 
The significant feature of molecular cloning procedures is the 
ability to produce essentially unlimited amounts of any required 
DNA sequence in absolute purity. This is a consequence of the 
fact that any recombinant derives originally from a single 
plasmid or bacteriophage DNA molecule. Therefore any gene 
sequence for which a means of identification is available can be 
purified to homogeneity from the 10" other DNA sequences in 
a mammalian genome or the 104 mRNA sequences present in 
the cytoplasm of a tissue or cell type. 
DNA Sequencing Procedures 
Once a particular DNA fragment has been isolated and 
identified, its nucleotide sequence can be readily determined. 
In fact, due to major developments in chemical [21] and enzymic 
[22] sequencing procedures, including the use of single-stranded 
DNA phage [23], it is now simpler to derive the amino acid 
sequence of a protein from its DNA sequence than by conven­
tional protein sequencing. In addition, portions of proteins, such 
as the C- and N-terminal peptides of procollagen, are often 
difficult or impossible to isolate in appreciable quantities. Direct 
sequencing of the DNA or the mRNA complement enables the 
amino acid sequence of such regions of proteins to be readily 
determined. An essential adjunct to the ability to determine 
nucleotide sequences has been the development of computer 
technologies to store, handle, compare and analyse sequence 
data. A comprehensive review of these technologies has recently 
been published [24]. 
RESULTS 
Uses of Type I Collagen Specific Gene Sequences 
Purified collagen mRNA can be copied into DNA using the 
enzyme reverse transcriptase. Such DNA complementary se­
quences, or these same sequences cloned into bacterial plas­
mids, can be used for a variety of investigations of the regulation 
of collagen gene expression. In addition, collagen specific cDNA 
probes can be used to isolate genomic collagen sequences from 
DNA libraries in recombinant bacteriophage. This in turn yields 
additional probes specific for collagen gene sequences. A list of 
some of the potential areas of investigation using collagen­
specific sequence probes is given in Table 1. To demonstrate 
these uses, the results of such investigations using type I colla­
gen-specific cDNAs and cloned sequences from the a2 chains of 
type I collagen will be considered in detail. 
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TABLE I. Potential uses of collagen·gene sequence specific probes 
1. Investigate the regulation of collagen gene expression at the tanscrip­
tional and translational level. 
2. Through analysis of mRNA or gene sequence, determine and analyse 
the structure of collagen proteins, particularly precursor segments 
which may be difficult to isolate. 
3. Isolate the genes coding for collagen chains to study their structure 
and the structure of potential regulatory sequences within, or 
flanking the genes. 
4. Investigate the evolution of collagen genes. 
5. Determine the number of copies of the genes encoding collagen 
chains. 
6. Localize collagen genes to specific chromosomes and to look for 
possible linkage between different collagen genes on the same 
chromosome. 
7. Study genetic disorders of connective tissue where altered or absent 
collagen is implicated. 
Regulation of Expression of Type I Collagen 
Type I collagen consists of 3 polypeptide chains, two al (I) 
chains and one a2 chain. Each of these chains is synthesized as 
precursor forms, termed pro collagen chains, with extensions to 
the a chains at both the N- and C-terminal ends [1]. The size 
of pro collagen proa chains is approximately 1500 amino acids 
and the mature a-chains are about 1,000 amino acids long. 
When purified type I collagen mRNA is isolated and copied 
into DNA, a mixture of both al [1] and a2 pro collagen mRNA 
sequence copies is obtained. Such type I collagen cDNAs have 
been prepared from chick [8,10,25], sheep [3,12], mouse [11] 
and human [13] type I pro collagen mRNA, and have been used 
to study regulatory events in a variety of different cell and 
tissue systems. 
Cultured fibroblasts: Collagen production declines markedly 
in primary cultures of avian tendon cells maintained in vitro. 
Analysis of the levels of type I pro collagen mRNA both by cell 
free translation, and by hybridization with a chick type I 
collagen-specific cDNA [8], shows a parallel decline in type I 
collagen mRNA [8]. Similarly, when cultured chick embryos 
are transformed with Rous sarcoma virus, the amounts of 
pro collagen mRNA, measured by cell-free translation [8,26,27] 
or with cDNA [8,25], decline sharply and parallel the marked 
decline in collagen production. Furthermore, using cloned 
cDNA probes specific for the two different mRNAs it was 
shown that levels of both pro al (1) and pro a2 mRNA decline. 
In these situations, therefore, it is likely that the levels of type 
I pro collagen mRNAs are the major determinants of collagen 
production. Indeed, the demonstration [29] that a2 pro collagen 
mRNA precursors also decline following Rous-sarcoma virus 
transformation of chick embryo fibroblasts strongly suggests 
that the decline in collagen mRNA levels is mediated by tran­
scriptional control mechanisms. Such mechanisms may also 
mediate the decline in procollagen production in mouse sarcoma 
virus-transformed 3T3 fibroblasts, and the fluctuation of colla­
gen synthesis levels during the cell cycle in 3T6 mouse embryo 
fibroblasts [11]. 
In contrast to such transcriptional mechanisms, translational 
and postranslational mechanisms significantly influence colla­
gen production in culture human fetal lung fibroblasts. The 
levels of type I pro collagen mRNA are twice as high in confluent 
cells as in log phase cells, while log phase cells actually synthe­
size slightly more type I procollagen per cell than do confluent 
cells [30]. Thus, log phase and confluent human lung fibroblasts 
clearly use their type I procollagen mRNA complements with 
different efficiencies. Additionally, the intracellular degradation 
of newly synthesized collagen has also been demonstrated to be 
a significant determinant of collagen production in these cells 
[30,31]. 
Developing tissues: In embryonic chick calvaria, the produc­
tion of type I collagen increases greatly as embryonic develop­
ment proceeds. This is accompanied by a parallel increase in 
the levels of type I procollagen mRNA [32]. During the fetal 
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development of sheep lung and tendon, type I procollagen 
mRNA levels also parallel the synthesis of collagen by these 
tissues [12]. In these situations, therefore, mRNA levels are 
likely the major determinants of collagen production. In fetal 
sheep skin, however, the synthesis of collagen falls approxi­
mately lO-fold over the last half of fetal life, while the levels 
and activity of type I pro collagen mRNA remain constant at 
the high levels found in early fetal life [12]. In this tissue, 
therefore, mechanisms acting at the translational or post-trans­
lational levels seem to playa major role in determining the 
amount of collagen synthesis. 
Cloned Collagen cDNA Sequences 
A number of recombinant plasmids containing parts of the 
sequence of the mRNAs for type I collagen have been con­
structed. The recombinants containing a2 collagen sequences, 
together with some of their properties, are listed in Table II. 
Several of these cDNA clones, have been extensively sequenced 
[35-37] and this has allowed the deduction of the C-terminal 
propeptide amino acid sequences for both the al (I) and a2 
procollagen chains of the chick. Additional insights observed 
from these DNA sequence determinations include the demon­
stration of a striking conservation of sequences in certain re­
gions of the chick a1 (I) and a2 C-terminal propeptides, and a 
marked difference in G + C content and tRNA codon usage 
between the chick al (I) and a2 mRNAs [35]. It is important to 
point out, however, that during the cloning process, sequence 
rearrangement:; can occur [35,37] particularly with al (I) cDNA 
clones. Although it is not clear why this process occurs, it 
necessitates careful validation of cDNA sequence data with 
other, independently isolated clones and/or protein sequence 
data 
Cloned Collagen Gene Sequences 
The availability of collagen cDNA sequences, and genomic 
DNA libraries carried in recombinant bacteriophages, has al­
lowed the isolation and purification of a number of DNA 
fragments containing the genomic sequences of collagen genes. 
These recombinant bacteriophage carrying collagen gene frag­
ments, together with some of their properties, are listed in 
Table III. 
Analysis of 2 recombinant bacteriophage, SpC3 and SpC6 
[3], which together encode about 60% of the sheep a2 collagen 
gene, reveal that this gene, like the majority of eukaryotic genes 
that have been characterized, is not a continuous structure, but 
is so organized that the mRNA coding sequences (exons) are 
interrupted by large non-coding regions (introns). In this re­
spect, collagen genes have proved remarkably complex. These 
genes cover very large stretches of DNA and are interrupted by 
many introns. For example, the genetic information coding for 
approximately one half of the sheep a2 mRNA sequence is 
spread over 17 kilobases of DNA and is interrupted by at least 
17 introns [3,4]. Recently, a number of recombinant bacterio­
phage covering the entire chick a2 collagen gene have been 
isolated from a chick genome library [5-7]. This gene is ap­
proximately 37 kilobases long and is interrupted by at least 51 
introns. The discontinuous nature of most genes in higher 
organisms, and the possible origins and functions of this type of 
gene arrangement have been recently reviewed [35]. It is clear 
TABLE II. Cloned collagen eDNA sequences ---
Species Type Chain Name Properties Reference 
Chick a2 BR200 200 bp long, from 3' un- 9 
transla ted end of 
mRNA 
a2 pCg45 2500 bp long, covering 33, 35 
3' half of the mRNA 
Human a2 Hf-32 2200 bp, 3' half of 13 
mRNA 
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TABLE III. Cloned alpha-2 collagen gene sequences 
Species Name Properties Reference 
Sheep SpC3 Overlapping clones with 3, 4 
SpC7 Dr" A inserts of 15.3 and 
13.8 kb. Cover 60% of 
the gene at the 3' end, 
with a short 3' flanking 
sequence. 17 introns in 
SpC3, small (approxi-
mately 100 bp) exons in 
a-chain region. 
Chick COL 204, Seven overlapping clones 5,6, 39 
271, 421, covering 55 kb of DNA. 
031, 611, Include the 2 gene 
871,402 (37kb) plus 3' and 5' 
flanking sequences. 51 
introns, and 7 of 8 a-
chain exons of 54 bp, 1 
of 99 bp. 
Chick 10 over- Cover 40 kb of DNA, 80% 7 
lapping of the gene and 8 kb of 
clones 3' flanking seqlience. 
Exons in a-chain of 45, 
54 and 108 bp. 
Human HpCl 16.3 kb of DNA, contain- (Footnote 1) 
ing C-terminal peptide 




that such genes are transcribed into precursor RNA molecules 
that contain both the intron and exon sequences. To produce a 
mature and functional mRNA, the intron sequences must be 
removed, or spliced out, with absolute precision, since any error 
would change the reading frame of the mRNA. The fact that 
active pro collagen mRNA molecules are produced from precur­
sors that require at least 50 splicing steps is testimony to the 
precision of the splicing process. The exact mechanism of the 
splicing of mRNA precursors is not yet understood. 
Evolution of Collagen Genes 
In addition to the large number of introns interrupting the 
a2 collagen gene, the exons of the regions encoding the a chain 
have been visualized (by the technique of R-Iooping and elec­
tron-microscopic analysis) to be very short [4-7]. When regions 
containing to such a chain exons were sequenced, it was found 
that a very high proportion of them were 54 base pairs (bp) in 
length, that the first codon invariably coded for a glycine 
residue, and that the final codon specified an amino acid im­
mediately preceding the glycine residue that began a Gly-X-Y 
repeat. This observation led to the proposal [39] that collagen 
genes evolved from an ancestral gene of 54 bp in length by 
multiple duplications or amplification of a single genetic unit 
containing such an exon. Although exons in the chick a2 colla­
gen gene have been found that are not 54 bp, they do have 
lengths which are multiples of 9 bp, begin with a codon for 
glycine and end with a codon preceding a glycine residue. For 
example, in the chick a2 chain coding region of 45, 99 and 108 
base-pairs have been found. It is possible to postulate mecha­
nisms whereby such exons arose from the rearrangement of the 
ancestral 54 base pair segment; for example, the 108 bp exon 
coding for amino acids 964 to 999 in chick a2 chains [7] could 
arise from the fusion of two adjacent exons with the exact 
removal of intron sequence between them. Various recombi­
nation and mutation events could lead to exon sizes of 45 or 99 
bp, but all must involve the deletion of 9 bp, which correspond 
to that DNA sequence encoding one Gly-X-Y triplet. One 
prediction of this model of collagen evolution is that in the 
genes encoding other collagens where protein helicity is pre­
served, the exons will be either 54 bp or differ from 54 bp by 9 
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bp or multiples of 9 bp. It is important to point out, however, 
that this 54 bp concept applies only to the a-chain region of 
collagen; the exons specifying the N- and C-terminal pep tides 
of chick and sheep a2 collagen are clearly different, and larger, 
than the exons for the helical part of the chain [4,6,7,39]. 
The 54 bp model for collagen gene evolution is also in accord 
with the domain theory [40] postulate to explain the existent of 
discontinuous genes in eukaryotes. In this postulate, each exon 
codes for a unit of function in a polypeptide sequence. Segre­
gation of such units into exons surrounded by large stretches of 
non-coding intron sequence allows the possibility to rapidly 
rearrange different polypeptides functions together into new 
proteins by recombination within intron regions. It is worthy to 
note, however, that the chick vitellogenin gene, which codes for 
the 6.3 kilobase vitellogenin mRNA, has very small exons 
separated by 33 intervening sequences [41]. There is no evi­
dence to suggest an evolutionary history of this gene similar to 
that proposed for collagen genes. In addition, the gene coding 
for silk fibroin (a fibrous protein with a repetitive amino acid 
sequence) is coded for by a gene with only one intervening 
sequence [42]. It will be of interest to see whether other collagen 
genes show a structural organization similar to that of the chick 
a2 collagen gene, and whether any remnants of ancestral col­
lagen gene segments remain in the genes for proteins (such as 
acetylcholine esterase and Clq) which contain a collagenous 
triple helical region. 
Collagen Gene Localization and Gene Number 
The classic procedure for localization of genes on chromo­
somes involves the production of cell hybrids by fusion of cells 
from 2 different species. The random loss of chromosomes from 
one species in such hybrids allows the isolation of cells which 
contain only one chromosome from one species, and a full set 
from the other species. If a particular gene is expressed in such 
hybrids, and a means to distinguish between the same gene 
product of the 2 species exists, then the chromosome location 
of such a gene can be determined. This approach has been 
applied to human type I collagen expressed in mouse-human 
hybrid cells. Two separate groups have reported a gene locali­
zation on chromosome 7 [43] and 17 [44]. 
The availability of type and chain-specific collagen gene 
probes allows an additional approach to this problem, and may 
be useful in resolving the apparent discrepancy of finding type 
I collagen genes on two different chromosomes. It is possible, 
for example that the a2 chains of type I collagen (i.e., al (I) and 
(2) are present on 2 different chromosomes. One advantage of 
the use of DNA probes is that the gene in question need not be 
expressed in the hybrid cell. However, it is necessary to be able 
to distinguish between the same gene from 2 different species. 
The assignment of collagen genes to chromosomes will enable 
questions relating to the linkage of collagen genes for different 
chains and types to be approached. These questions can also be 
tackled with recombinant DNA techniques, by "walking" along 
the DNA in recombinant libraries to attempt to determine 
whether the genes for collagen chains lie close to each other on 
the same chromosome. However the enormous size of collagen 
genes, together with the technical limitations on the size of 
DNA fragments in DNA libraries, makes this a major under­
taking. 
To assess the possibility of tissue-specific collagen genes and 
to examine potential gene defects in hereditary connective 
tissue disorders it is necessary to know the number of copies for 
each collagen gene in the genome. Studies with uncloned DNA 
sequences have suggested that the genes for type I collagen in 
chick are not repeated many times in the genome [10]. In 
addition, preliminary studies indicate that the number of copies 
of an intron sequence in the sheep a2 collagen gene represented 
in the recombinant clone SpC7, is one per haploid genome (B 
Trapnell-personal communication). However, this does not ex­
clude the possibility of other nonidentical genes which are able 
to code for a2 collagen mRNA. 
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Analysis of Genetic Disorders of Connective Tissue 
The availability of collagen gene probes will have a significant 
impact on the study of heritable disorders of connective tissue. 
The approach of looking for abnormalities in gene structure by 
the technique of Southern blotting, and adapting this procedure 
for antenatal diagnosis, is now well established for the hemo­
globinopathies such as thalassemia and sickle cell disease [45]. 
In addition, the finding of polymorphic endonuclease restriction 
sites linked to particular gene defects [46] adds an important 
principle which is probably applicable to many other genetic 
diseases. The application of such techniques to studying con­
nective tissue disorders has recently been described [47] and 
will be discussed in detail elsewhere in this volume. The use of 
cloned collagen gene sequences will doubtless have a funda­
mental impact in the future in the understanding and diagnosis 
of disorders where a defect in collagen genes underlies the 
disease. 
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